Zoran Zdraveski, See Remarks at TScan Therapeutics, Inc. (TCRX), sold 329,372 shares at $5.78 ($1.9M) on 2024-08-23, disclosed to the SEC on 2024-08-27.
Open-market sale of $1.9M TCRX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.78 | 164,686 | $952K | 50.0% |
| 2 | $5.78 | 164,686 | $952K | 50.0% |
| Total | $5.78 avg | 329,372 | $1.9M | 100% |
| Filing → |